Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.
Purpose: We sought to exploit the heterogeneity afforded by patient-derived tumor xenografts (PDX) to first, optimize and identify robust radiomic features to predict response to therapy in subtype-matched triple negative breast cancer (TNBC) PDX, and second, to implement PDX-optimized image feature...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 49; no. 2; pp. 550 - 563 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | diagnostic images research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jan2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |